Dietary supplement

Koios Closes Acquisition of Retox Beverage Corp.

Retrieved on: 
Monday, April 25, 2022
Well, CSE, Immunity, News, Phrase, Risk, Regulation of tobacco by the U.S. Food and Drug Administration, Coeus, Legislation, Intention, Alertness, Food, MCT, Brain, Growth, Company, Memory, Environment, Europa Sports Park, Ketone, THIS, Health Canada, Acquisition, Disease, Health, THE, Dietary supplement, Risk management, Retox

Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well.

Key Points: 
  • Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well.
  • Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants.
  • Koios products have been shown to enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity.
  • Koios produces one of the only drinks in the world infused with MCT oil.

Momentous Announces a Multi-Year Partnership with the Huberman Lab Podcast and Dr. Andrew Huberman as a Scientific Advisor

Retrieved on: 
Monday, April 25, 2022
Lead, Sleep, PARK, Department of Defence, United States Air Force Scientific Advisory Board, NSF, Research, Health, Life, Brain, War Music (Vampire Rodents album), Department, Severe cognitive impairment, Mental health, Physiology, CO, Contract, Immune system, Movement, McKnight Foundation Collaborative Crop Research Program, Advisory board, Exercise, Education, Multimedia, Industry, Fitness, Partnership, McKnight Foundation, Department of Defense Serum Repository, Knowledge, Longevity, Medical device, Dietary supplement, Science

PARK CITY, Utah, April 25, 2022 /PRNewswire/ -- Momentous — a leader in human performance through supplementation and nutrition — announced today that Dr. Andrew Huberman, one of the most reputable scientists in the world, will join the company's Scientific Advisory Board. In addition, Momentous and Dr. Huberman's #1 Health & Fitness podcast, the Huberman Lab Podcast, are entering into a multi-year partnership together. Through this partnership and his advisory role, Dr. Huberman will leverage his scientific knowledge across multiple disciplines of brain and body health to support Momentous' growing stature in the human performance industry.

Key Points: 
  • In addition, Momentous and Dr. Huberman's #1 Health & Fitness podcast, the Huberman Lab Podcast, are entering into a multi-year partnership together.
  • Dr. Huberman joins that mission alongside the Momentous Scientific Advisory Board leaders, including Dr. Kelly Starrett, Jordan Mazur, Brandon McDaniel, Allison Brager, and others.
  • "We are beyond excited to partner with Dr. Huberman and the Huberman Lab Podcast.
  • In 2021, Dr. Huberman launched the Huberman Lab podcast with the objective of bringing free information around science to the masses.

Global Liver Cirrhosis Market to 2032 - Insight, Epidemiology and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Monday, April 25, 2022
Pharmaceutical, Health, Surgery, Epidemiology, Awareness, Report, Research, Diagnosis, Review, Cirrhosis, Disease, Dietary supplement, Copper, Pharmaceutical industry

The "Liver Cirrhosis - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Liver Cirrhosis - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's offering.
  • This report delivers an in-depth understanding of the Liver Cirrhosis, historical and forecasted epidemiology as well as the Liver Cirrhosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
  • The Liver Cirrhosis market report provides current treatment practices, emerging drugs, Liver Cirrhosis market share of the individual therapies, current and forecasted Liver Cirrhosis market Size from 2019 to 2032 segmented by seven major markets.
  • What would be the Liver Cirrhosis market growth till 2032, and what will be the resultant market Size in the year 2032?

Global Protein Supplements Market Report 2022: Based on Source, Animal-based Protein Supplements Led the Market with a Revenue Share of over 65% in 2021 - ResearchAndMarkets.com

Retrieved on: 
Monday, April 25, 2022
Food, Beverage, Online Retail, Health, Retail, Fitness & Nutrition, Immunity, Meat, Health, Bodybuilding, Awareness, Obesity, European Food Safety Authority, COVID-19, CDC, Milk, EFSA, Chinese Center for Disease Control and Prevention, CAGR, Patient, Protein, Diet, Application, Structured Product Labeling, Cheese, Glanbia, Organic acid, Millennials, USD, Duke Diet and Fitness Center, Asia-Pacific, Market share, USDA, Dietary supplement

The global protein supplements market size is expected to reach USD 42.81 billion by 2030.

Key Points: 
  • The global protein supplements market size is expected to reach USD 42.81 billion by 2030.
  • The growing number of fitness centers on account of rising millennials' interest in health and wellness is expected to drive the market over the forecast period.
  • The protein supplement manufacturing companies are primarily concentrated in Europe and North America owing to the abundant availability of raw materials.
  • The rising vegan population across the globe has compelled manufacturers to invest in R&D to innovate in plant-based protein supplements.

At 7.1% Global CAGR of Dairy Ingredients Market Size Worth $95502.25 Million, by 2028: Zion Market Research

Retrieved on: 
Monday, April 25, 2022
Milk, Functional food, Projection, Conditional sentence, Population, Research, DSM (company), CAGR, Confectionery, Clinical nutrition, Growth, OPC Historical Data Access, Casein, Strategic management, USD, Animal feed, Industry, Prevalence, Whey protein, Health, Feed manufacturing, Fine chemical, Dietary supplement, Lactose, Pediatrics, Others, Application, Bakery

Key Industry Insights & Finding of the Dairy Ingredient Market Reports:

Key Points: 
  • Key Industry Insights & Finding of the Dairy Ingredient Market Reports:
    As per the analysis shared by our research analyst, the Dairy Ingredient Market is expected to grow annually at a CAGR of around 7.1% (2022-2028).
  • Dairy Ingredient in the Asia Pacific region is projected to exhibit growth at the fastest CAGR through 2028.
  • Increasing focus on health and fitness is also expected to boost the Dairy Ingredient market growth over the forecast period.
  • Rising population, increasing consumption of Dairy Ingredient, and increasing demand for Dairy Ingredient in multiple food sectors are other factors that will influence the Dairy Ingredient market potential in the long run.

Tremelimumab accepted under Priority Review in the US for patients with unresectable liver cancer in combination with Imfinzi

Retrieved on: 
Monday, April 25, 2022
Science, Cardiology, Biotechnology, Research, Oncology, Health, FDA, Clinical Trials, Patient, Sorafenib, Society, Prednisone, Medicine, Liver cancer, Food, Incidence, HCC, STRIDE, Death, Prescription Drug User Fee Act, Infection, Warning, Pneumonitis, Radiation, Creatinine, AstraZeneca, Food and Drug Administration Amendments Act of 2007, Administration, FDA, BLA, Risk, Priority review, Cancer, Survival, Pharmaceutical industry, Dietary supplement, Vaccine, Durvalumab

Of the patients who received IMFINZI (475), 1.1% were fatal and 2.7% were Grade 3 adverse reactions.

Key Points: 
  • Of the patients who received IMFINZI (475), 1.1% were fatal and 2.7% were Grade 3 adverse reactions.
  • Immune-mediated colitis occurred in 2% (37/1889) of patients receiving IMFINZI, including Grade 4 (
  • Fatal adverse reactions occurred in 4.9% of patients receiving IMFINZI plus chemotherapy
    The safety and effectiveness of IMFINZI have not been established in pediatric patients.
  • Phase 3 randomized, open-label, multicenter study of tremelimumab and durvalumab as first-line therapy in patients with unresectable hepatocellular carcinoma: HIMALAYA.

Equillium Announces Three Poster Presentations at the Transplantation & Cellular Meetings of the ASTCT and CIBMTR

Retrieved on: 
Monday, April 25, 2022
Oncology, Health, Clinical Trials, Research, Science, Biotechnology, Society, Irritation, EDGAR, Feedback, HSCT, Transplant, Nausea, Pharmacokinetics, Adult, Alopecia areata, Semipermeable membrane, Center, Rash, Private Securities Litigation Reform Act, Serum, Center for International Blood and Marrow Transplant Research, CXCL12, Steroid, Risk, Patient, GVHD, NCT, Jaundice, Skin discoloration, TEM, Mortality, Trial of the century, Nasdaq, Itch, CD6, SEC, Forward-looking statement, EQUIP, Safety, McMillan, Disease, Partnership, Vomiting, Diarrhea, Salt Palace, Therapy, Association, Cancer, Research, Pharmaceutical industry, Vaccine, Dietary supplement, Sales, Degenerative disease, Efficacy, Itolizumab

The hybrid meetings are taking place virtually and in-person at the Salt Palace Convention Center in Salt Lake City, April 23 26, 2022.

Key Points: 
  • The hybrid meetings are taking place virtually and in-person at the Salt Palace Convention Center in Salt Lake City, April 23 26, 2022.
  • Symptoms of GVHD include rash, itching, skin discoloration, nausea, vomiting, diarrhea, and jaundice, as well as eye dryness and irritation.
  • All forward-looking statements contained in this press release speak only as of the date on which they were made.
  • Equillium undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

DrFirst Pharmacy Solution Earns Edison Award for Excellence in Commercial Technology, Consumer Safety

Retrieved on: 
Monday, April 25, 2022
IBM Lotus SmartSuite, Marketing, Tertiary Education Quality and Standards Agency, Leadership, Hospital, Patient, Artificial intelligence, Edison Awards, PBS, News Hour, Efficiency, Pharmacy, Technology, Death, EHR, Solution, Safety, Approximation error, Dietary supplement, Pharmaceutical industry

ROCKVILLE, Md., April 25, 2022 /PRNewswire/ -- DrFirst's SmartSuite for Pharmacy has earned a prestigious Bronze Edison Award in the Commercial Technology, Consumer Safety Category, honoring the solution's innovative use of artificial intelligence (AI) to improve safety for patients and efficiency for pharmacies. The Edison Awards is a global leader in recognizing and honoring the best in innovation and excellence in the development of new products and services to create a positive impact on the world.

Key Points: 
  • ROCKVILLE, Md., April 25, 2022 /PRNewswire/ -- DrFirst's SmartSuite for Pharmacy has earned a prestigious Bronze Edison Award in the Commercial Technology, Consumer Safety Category, honoring the solution's innovative use of artificial intelligence (AI) to improve safety for patients and efficiency for pharmacies.
  • "Being recognized with an Edison Award is one of the highest accolades a company can receive for innovation in product development and business," said G. Cameron Deemer, president at DrFirst.
  • This year's Edison Awards finalists were chosen by senior business executives and academics from across the globe, whose votes acknowledge excellence in meeting the award criteria.
  • The Edison Awards is an annual competition designed to honor excellence in new product and service development, marketing, human-centered design and innovation.

China Energy Drink Market Report 2022-2027: Share, Insight, Forecasts, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis - ResearchAndMarkets.com

Retrieved on: 
Monday, April 25, 2022
Food, Beverage, Retail, Online, Vitamin, Water, Red Bull, Monster Beverage, Culture, COVID-19, Caffeine, Rage, Insight, Athlete, Alertness, Energy drink, Dietary supplement, Urbanization, Food, Coca-Cola, Coffee, LMT, Industry, Quality of life, Exercise, Carnitine, Taurine, Teahouse, Bottled water, Grocery store, Hypermarket, Foodservice, PepsiCo, Supermarket, Energy, Growth

The "China Energy Drink Market, Share, Insight, Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "China Energy Drink Market, Share, Insight, Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Similar to other countries, energy drinks are most favoured among young people in China who drink them as a normal beverage.
  • Still, in recent years, imported energy drinks to China are growing, and the highest consumption group is the more youthful generation who find energy drinks as some fashion and trend.
  • In terms of type, China's energy drinks market is segmented into Energy drinks, Energy shots, and Energy mixers.

By 2028, Global Water Testing and Analysis Market Size and Statistical Data Will Surpass USD 6,039.76 Billion at CAGR of 5.9% Industry Trends & Forecast Report by Zion Market Research

Retrieved on: 
Monday, April 25, 2022
Water, Projection, Government, PH meter, Intertek, Water testing, Population, Regional Economics Applications Laboratory, Delivery of water to households far from sources of safe water, Water quality, Electrical conductivity meter, Continuity, CAGR, Refractometer, Silicon bandgap temperature sensor, Food, OPC Historical Data Access, Application, Radioactive decay, Environment, Mining, Solution, Drink, Metre, Agriculture, Strategic management, Aquaculture, Growth, USD, Drinking, Partnership, Nephelometer, Health, Research, Recycling, Renewable energy, Lithium, Dietary supplement, Cork Harbour, Analysis

Key Industry Insights & Finding of the Water Testing and Analysis Market Reports:

Key Points: 
  • Key Industry Insights & Finding of the Water Testing and Analysis Market Reports:
    As per the analysis shared by our research analyst, the Water Testing and Analysis Market is expected to grow annually at a CAGR of around 5.9% (2022-2028).
  • This will majorly increase the demand for Water Testing and Analysis solutions and services and hence drive the Water Testing and Analysis market growth through 2028.
  • Water Testing and Analysis Market: Restraints
    Water Testing and analysis market will see steady growth through 2028 but the high cost of equipment will have a major restraining effect on the global Water Testing and Analysis market potential.
  • This will be a major obstacle for Water Testing and Analysis market growth in economies with low spending potential and hence constrain global Water Testing and Analysis market potential.